Skip to main content

Murdock Hunter R.'s Form 4 filing

Axsome Therapeutics, Inc. (AXSM) · filed Jun 23, 2025

Accession no.
0000950170-25-089158
Filed
Jun 23, 2025
Trade date
Jun 20-23, 2025
Filing delay
3 days
Rule 10b5-1 plan
Checked

This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $1.37M. It was filed 3 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Murdock Hunter R.CIK 0001934008Officer (General Counsel)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jun 20, 2025Common StockMOption exerciseAcquired+7,500$29.91+$224,3257,500Direct
Jun 20, 2025Common StockSSaleDisposed−7,500$102.47−$768,5250Direct
Jun 23, 2025Common StockMOption exerciseAcquired+6,014$29.91+$179,878.746,014Direct
Jun 23, 2025Common StockSSaleDisposed−6,014$100.12−$602,121.680Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jun 20, 2025Common StockMOption exerciseDisposed−7,500$0.00$022,383Direct
Jun 23, 2025Common StockMOption exerciseDisposed−6,014$0.00$016,369Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)